Mexico will participate in clinical trials of a vaccine being developed in Italy against the novel coronavirus (covid-19), Mexican Foreign Affairs Minister Marcelo Ebrard said on Tuesday, Aug. 25.
“We are very grateful to Italy,” Ebrard said at a press conference, accompanied by Mexican President Andrés Manuel Lopez Obrador (AMLO) and authorities from the health sector.
Italy’s Lazzaro Spallanzani National Institute for Infectious Diseases agreed to Mexico’s participation in the studies of the GRAd-COV2 vaccine, said Ebrard.
As of Monday, Aug. 24, Mexico had reported 60,800 deaths from covid-19 and 563,705 cases of infection since the first case was confirmed on Feb. 28.
Mexico ranks third worldwide in covid-19 deaths, after the United States and Brazil.